hccpjournal.com/article
Bottom,Top,Right1
  • Log on
  •   BioMed Central
  • Journals
  • Gateways
Hereditary Cancer in Clinical Practice
official impact factor 1.68
Search for
Advanced search
  • Home
  • Articles
  • Authors
  • Reviewers
  • About this journal
  • My Hereditary Cancer in Clinical Practice

Submit a manuscript Register Sign up for article alerts Contact us Follow
BioMed Central
Support

Explore journal

  •  Editorial Board
  •  Instructions for authors
  •  FAQ
Advertisement

Articles

  • All articles
  • Most viewed RSS
  • Archive
  • Supplements

Hereditary Cancer in Clinical Practice publishes selected collections of research articles, conference proceedings, reviews and reports as supplements, which are free to access online. All articles published in supplements are subject to peer review; meeting abstracts undergo review and selection by the conference. Find out more about publishing a supplement with BioMed Central.

Volume 10 Supplement 2

Familial Aspects of Cancer 2011 Research and Practice

Meeting abstracts

Familial Aspects of Cancer 2011 Research and Practice: A combined meeting of kConFab, Australian Breast Cancer Family Study, Australian Colorectal Cancer Family Study, Australian Ovarian Cancer Study, Family Cancer Clinics of Australia and New Zealand and kConFab

Kingscliff, Australia

23-26 August 2011

Edited by Rodney Scott

Meeting abstract   Open Access

Clinical management of women in BRCAX families: issues and controversies

G Mitchell Hereditary Cancer in Clinical Practice 2012, 10(Suppl 2):A1 (12 April 2012)

Full text | PDF

Meeting abstract   Open Access

Polyposis syndromes– what to do when genotyping seems not informative

F Macrae Hereditary Cancer in Clinical Practice 2012, 10(Suppl 2):A2 (12 April 2012)

Full text | PDF

Meeting abstract   Open Access

Inherited and de novo germline TP53 mutations in adult-onset sarcoma

DM Thomas, ML Ballinger, International Sarcoma Kindred Study Consortium Hereditary Cancer in Clinical Practice 2012, 10(Suppl 2):A3 (12 April 2012)

Full text | PDF

Meeting abstract   Open Access

I just did it for the kids: mothering in the context of living with an increased risk of ovarian cancer

A McEwen Hereditary Cancer in Clinical Practice 2012, 10(Suppl 2):A4 (12 April 2012)

Full text | PDF

Meeting abstract   Open Access

Are women at high risk for serous gynaecological cancer (SGC) opting for risk-reducing salphingo-oophorectomy motivated by high levels of anxiety and risk perceptions?

B Meiser, MA Price, PN Butow, J Karatas, M Charles, KA Phillips, kConFab Psychosocial and Clinical Follow-Up groups, kConFab investigators Hereditary Cancer in Clinical Practice 2012, 10(Suppl 2):A5 (12 April 2012)

Full text | PDF

Meeting abstract   Open Access

Rehabilitating the sick role: post-surgical experiences of high risk women who undergo risk reducing mastectomy

N Hallowell, L Heiniger, B Baylock, M Price, P Butow, kConFab Psychosocial Group, kConFab Investigators Hereditary Cancer in Clinical Practice 2012, 10(Suppl 2):A6 (12 April 2012)

Full text | PDF

Meeting abstract   Open Access

Use of SDHB immunohistochemistry to identify germline mutations of SDH genes

AJ Gill Hereditary Cancer in Clinical Practice 2012, 10(Suppl 2):A7 (12 April 2012)

Full text | PDF

Meeting abstract   Open Access

Dissecting genetic pathways in schwannomatosis and malignant rhabdoid tumour

E Algar Hereditary Cancer in Clinical Practice 2012, 10(Suppl 2):A8 (12 April 2012)

Full text | PDF

Meeting abstract   Open Access

An update of clinical issues from InSIGHT 2011

L Lipton Hereditary Cancer in Clinical Practice 2012, 10(Suppl 2):A9 (12 April 2012)

Full text | PDF

Meeting abstract   Open Access

Selecting women for breast cancer chemoprevention and what agents should be used

J Cuzick Hereditary Cancer in Clinical Practice 2012, 10(Suppl 2):A10 (12 April 2012)

Full text | PDF

Meeting abstract   Open Access

Association of tamoxifen use and reduced risk of contralateral breast cancer for BRCA1 and BRCA2 mutation carriers

KA Phillips, RL Milne, MA Rookus, D Goldgar, M Friedlander, SA McLachlan, S Buys, AC Antoniou, K Birch, MB Terry, DF Easton, P Weideman, M Daly, N Andrieu, EM John, MJ Hooning, IL Andrulis, T Caldes, H Olsson, JL Hopper Hereditary Cancer in Clinical Practice 2012, 10(Suppl 2):A11 (12 April 2012)

Full text | PDF

Meeting abstract   Open Access

Bowel cancer chemoprevention - ready for the clinic?

J Burn Hereditary Cancer in Clinical Practice 2012, 10(Suppl 2):A12 (12 April 2012)

Full text | PDF

Meeting abstract   Open Access

Risk-reducing surgery for breast and ovarian cancer risks - where are we now?

N Hallowell, B Baylock, L Heiniger, M Price, P Butow Hereditary Cancer in Clinical Practice 2012, 10(Suppl 2):A13 (12 April 2012)

Full text | PDF

Meeting abstract   Open Access

"It's not even about her it's about the whole family": accounts of participation in a family cancer study

H Shipman, A Clarke Hereditary Cancer in Clinical Practice 2012, 10(Suppl 2):A14 (12 April 2012)

Full text | PDF

Meeting abstract   Open Access

The experiences of research participants offered genetic test results as a result of taking part in a population based ovarian cancer research study?

MA Young, S Wake, K Alsop, D Bowtell, G Mitchell, The Australian Ovarian Cancer Study Group, L Plunkett, A Crook, M Gleeson, N Hallowell Hereditary Cancer in Clinical Practice 2012, 10(Suppl 2):A15 (12 April 2012)

Full text | PDF

Meeting abstract   Open Access

Peer live supervision in the familial cancer setting

M Kentwell, A Sexton, L Hodgkin, Y Bylstra, M Bogwitz, K Mann, J Taylor, M Sahhar, F Pearce, I Winship, GJ Lindeman Hereditary Cancer in Clinical Practice 2012, 10(Suppl 2):A16 (12 April 2012)

Full text | PDF

Meeting abstract   Open Access

Looking for RED FLAGS: identifying and supporting patients at risk of adverse psychological responses to genetic counselling and testing

S Buscombe Hereditary Cancer in Clinical Practice 2012, 10(Suppl 2):A17 (12 April 2012)

Full text | PDF

Meeting abstract   Open Access

A state-wide population-based program for detection of Lynch syndrome based upon immunohistochemical and molecular testing of colorectal tumours

L Schofield, F Grieu, J Goldblatt, B Amanuel, B Iacopetta Hereditary Cancer in Clinical Practice 2012, 10(Suppl 2):A18 (12 April 2012)

Full text | PDF

Meeting abstract   Open Access

Hyperplastic polyposis syndrome: endoscopic imaging, phenotypic charcteristics and molecular pathways

KS Boparai, E Dekker, CJM van Noesel Hereditary Cancer in Clinical Practice 2012, 10(Suppl 2):A19 (12 April 2012)

Full text | PDF

Meeting abstract   Open Access

Serrated polyposis syndrome and colonoscopic surveillance: who is it safe to follow?

S Parry, S Woodall, G Willdridge, MD Walsh, DD Buchanan, C Rosty, JP Young Hereditary Cancer in Clinical Practice 2012, 10(Suppl 2):A20 (12 April 2012)

Full text | PDF

View more

  • Terms and Conditions
  • Privacy statement
  • Press
  • Information for advertisers
  • Jobs at BMC
  • Support
  • Contact us

© 2013 BioMed Central Ltd unless otherwise stated. Part of Springer Science+Business Media.